Home
News
Media
All VideosClinical Trials in ProgressImmunoLogicNews Network
Partners
More
CME/CE
Conferences
Sponsored

Subscribe

  • Home
  • News
  • Media
    • Partners
    • CME/CE
    • Conferences
    • Sponsored
    • Subscribe
    Advertisement

    Susan Foy, PhD

    Advertisement

    Articles by Susan Foy, PhD

    Susan Foy, PhD

    Susan Foy, PhD, on Evaluating Personalized, Neoantigen-Specific T Cell Therapy in Solid Tumors

    BySusan Foy, PhD
    November 10th 2022

    The CRIPSR-edited neoantigen-specific T cell therapy demonstrated safety and feasibility in the first-in-human PACT-0101 study presented at SITC 2022.

    Advertisement

    Latest Updated Articles

    • Uptake of Nononcology Gene Therapy Remains Slow in Hematology
      Uptake of Nononcology Gene Therapy Remains Slow in Hematology

      Published: August 16th 2024 | Updated: August 19th 2024

    • Phase 3 Trial Seeks to Continue Supporting Arsa-Cel Gene Therapy for MLD
      Phase 3 Trial Seeks to Continue Supporting Arsa-Cel Gene Therapy for MLD

      Published: March 18th 2024 | Updated: June 3rd 2024

    • Peter A. Riedell, MD, from the David and Etta Jonas Center for Cellular Therapy, University of Chicago
      Rapcabtagene Autoleucel Shows Promise for DLBCL in Updated Phase 2 Data

      Published: December 7th 2024 | Updated:

    • Aimee C. Talleur, MD
      Aimee C. Talleur, MD, on Predicting Response and Toxicity to Cell Therapy

      Published: December 12th 2022 | Updated:

    •  David Telander, MD, Ph
      RPE Cell Therapy Shows Improvements in Early GA With AMD

      Published: July 14th 2024 | Updated:

    • Multi-Characteristic Opsin Gene Therapy for Retinitis Pigmentosa Improves Multiple Measures of Vision
      Multi-Characteristic Opsin Gene Therapy for Retinitis Pigmentosa Improves Multiple Measures of Vision

      Published: May 18th 2023 | Updated:



    Advertisement
    Advertisement

    Trending on CGTlive®

    1

    Nanoscope Nabs RMAT Designation for Retinitis Pigmentosa Gene Therapy MCO-010

    2

    CGTLive®’s Weekly Rewind – September 5, 2025

    3

    Preclinical Evidence for PH1 Gene Therapy

    4

    Robert Alexander Wesselhoeft, PhD, on the Therapeutic Potential of Circular RNA

    5

    VeonGen Snags FDA RMAT Designation for Stargardt Gene Therapy VG801

    • About Us
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Do Not Sell My Information
    • Privacy
    Contact Info

    2 Commerce Drive
    Cranbury, NJ 08512

    609-716-7777

    • HCP Live
    • Contagion Live
    • CGT Live
    • Neurology Live
    • Oncology Live
    • Contemporary Pediatrics
    • Contemporary OBGYN
    • Urology Times
    • The Educated Patient
    HCP Live
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us